Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C38H49N9O5 |
| Molecular Weight | 711.853 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC2=CC=C3C=CC=CC3=C2)C(=O)N[C@H](CC4=CC=CC=C4)C(=O)N[C@@H](CCCCN)C(N)=O
InChI
InChIKey=NEHWBYHLYZGBNO-BVEPWEIPSA-N
InChI=1S/C38H49N9O5/c1-38(2,41)37(52)47-32(21-28-22-42-23-43-28)36(51)46-31(20-25-15-16-26-12-6-7-13-27(26)18-25)35(50)45-30(19-24-10-4-3-5-11-24)34(49)44-29(33(40)48)14-8-9-17-39/h3-7,10-13,15-16,18,22-23,29-32H,8-9,14,17,19-21,39,41H2,1-2H3,(H2,40,48)(H,42,43)(H,44,49)(H,45,50)(H,46,51)(H,47,52)/t29-,30+,31+,32-/m0/s1
Ipamorelin is a new and potent synthetic pentapeptide which has distinct and specific growth hormone (GH)-releasing properties. Ipamorelin mimics ghrelin and binds to the ghrelin receptor (or GH secretagogue receptor, GHSR) in the brain, thereby selectively stimulating the release of GH from the pituitary gland. This results in increased plasma GH levels, which would affect many biological processes. Besides its presence in the brain, GHSR can also be found in the gastrointestinal tract, heart, lung, liver, kidney, pancreas, adipose tissue and immune cells. Unlike other GH releasing peptides, ipamorelin only stimulates GH release in a manner very similar to that of growth hormone releasing hormone.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01280344
Ipamorelin 0.06 mg/kg, TID (3 investigational drug infusions)
Route of Administration:
Intravenous
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C76358
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
||
|
WIKIPEDIA |
Designer-drugs-Ipamorelin
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID80168955
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
PRIMARY | |||
|
SUB08269MIG
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
PRIMARY | |||
|
100000083138
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
PRIMARY | |||
|
IPAMORELIN
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
PRIMARY | |||
|
Y9M3S784Z6
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
PRIMARY | |||
|
7639
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
PRIMARY | |||
|
C81120
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
PRIMARY | |||
|
DB12370
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
PRIMARY | |||
|
C114611
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
PRIMARY | |||
|
CHEMBL58547
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
PRIMARY | |||
|
170851-70-4
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
PRIMARY | |||
|
9831659
Created by
admin on Mon Mar 31 18:32:50 GMT 2025 , Edited by admin on Mon Mar 31 18:32:50 GMT 2025
|
PRIMARY |
ACTIVE MOIETY